Venlafaxine
Venlafaxine is SNRI (Selective Serotonin and Nor-adrenaline Reuptake Inhibitor) popularly used as antidepressant. It received approval for medical use in 1993. Chemically, it is bicyclic […]
Month: January 2022
Screening of Anti-parkinsonism Drugs
Parkinson’s disease is a progressive neurological disorder with symptoms like muscular rigidity, tremor, dyskinesia, postural and gait abnormalities. It is characterized by death of dopaminergic […]
Varenicline
Varenicline is the first approved nicotinic receptor partial agonist to treat smoking addiction. It is a prescription medicine and is not available OTC. It was […]
Adverse Drug Reactions (ADR)
Adverse drug reaction (ADR) are unwanted effects of drugs in normal therapeutic dose. It’s definition by WHO (World Health Organization) is ‘any response to a […]
Duloxetine Pharmacology
Duloxetine is dual serotonin and nor-adrenaline reuptake inhibitor (SNRI) and is a second-generation anti- depressant. It was originally discovered in 1993. However, duloxetine received its […]